Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB):: regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease
Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB):: regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease
复制标题
DOI:
10.1016/s0014-5793(99)00586-4
复制
发表时间:
1999-05-28
期刊:
影响因子:
3.5
通讯作者:
Jörnvall, H
中科院分区:
文献类型:
--
作者:
Oppermann, UCT;Salim, S;Jörnvall, H
The intracellular amyloid beta-peptide (A beta) binding protein, ERAB, a member of the short-chain dehydrogenase/reductase (SDR) family, is known to mediate apoptosis in different cell lines and to be a class II hydroxyacyl-CoA dehydrogenase. The A beta peptide inhibits the enzymatic reaction in a mixed type fashion with a K-i of 1.2 mu mol/l and a K-iES of 0.3 mu mol/l, using 3-hydroxybutyryl-CoA. The peptide region necessary for inhibition comprises residues 12-24 of A beta 1-40, covering the 16-20 fragment, which is the minimum sequence for the blockade of A beta polymerization, but that minimal fragment is not sufficient for more than marginal inhibition. The localization of ERAB to the endoplasmic reticulum and mitochondria suggests a complex interaction with components of the programmed cell death machinery, The interaction of A beta with ERAB further links oxidoreductase activity with both apoptosis and amyloid toxicity. (C) 1999 Federation of European Biochemical Societies.